Summary
During the past decade, converging lines of evidence have linked the abnormal release or leak of excitatory amino acids to the neurodegeneration associated with a wide range of pathologies including cerebral ischemias, Huntington’s disease, and AIDS dementia (Coyle and Robinson, 1987; Lipton, 1994; Meldrum, 1994). Pharmacological studies indicate that activation of both ionotropic and metabotropic glutamate receptors can substantially contribute to excitotoxic cell damage (Choi, 1992; Pizzi et al, 1993; Sheardown et al., 1993; Xue et al., 1994). Based on these findings, therapeutic strategies based on blunting or blocking glutamatergic transmission may be useful in treating a variety of neurodegenerative disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bakshi R, Faden AI (1990) Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res 507: 1–5
Beaughard M, Michelin M, Massingham R (1990) Effects of the putative glycine antagonist HA-966 on the neurological and histological changes induced by transient global ischemia in rats and gerbils. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 275–280
Boje K (1994) In vitro and in vivo studies with glycine partial agonists: a novel strategy for preventing NMDA receptor—mediated tissue damage. In: Palfreyman MG, Reynolds IJ, Skolnick P (eds) Direct and allosteric control of glutamate receptors. CRC Press, Boca Raton, pp 119–126
Boje KM, Wong G, Skolnick P (1993) Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar cell cultures. Brain Res 603: 207–214
Choi DW (1992) Excitotoxic cell death. J Neurobiol 23: 1261–1276
Evoniuk GE, Hertzman RP, Skolnick P (1991) A rapid method for evaluating the behavioral effects of dissociative anesthetics in mice. Psychopharmacol 105: 125–128
Fossom LH, Von Lubitz DKJE, Lin RC-S, Skolnick P (1995a) Neuroprotective actions of 1-aminocyclopropanecarboxylic acid, a partial agonist at strychnine-insensitive glycine sites. Neurol Res 17: 265–269
Fossom LH, Basile AS, Skolnick P (1995b) Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters NMDA receptor function and subunit composition. Mol Pharmacol 48: 981–987
Hartley DM, Moyner H, Colamarino SA, Choi DW (1990) 7-Chlorokynurenate blocks NMDA receptor mediated neurotoxity in murine cortical culture. Eur J Neurosci 2: 291–295
Isaac L, van Zandt O’Malley T, Ristic H, Stewart P (1990) MK-801 blocks dynorphin A (l–13)-induced loss of the tail-flick reflex in the rat. Brain Res 531: 83–87
Kleckner NW, Dingledine R (1988) Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835–837
Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature 358: 36–41
Laurie DJ, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol 268: 335–345
Layer RT, Bland LR, Skolnick P (1993) MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity. Brain Res 625: 38–44
Lipton SA (1994) Ca2+, N-methyl-D-aspartate receptors, and AlDS-related neuronal injury. Int Rev Neurobiol 36: 1–27
Lombardi G, Moroni F, Moroni F (1994) Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur J Pharmacol 271: 489–495
Long JB, Skolnick P (1994) 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur J Pharmacol 261: 295–301
Long JB, Rigamonti DD, Oleshansky MA, Wingfield CP, Martinez-Arizala A (1994) Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther 269: 358–366
Marvizon JC, Lewin AH, Skolnick P (1989) 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J Neurochem 52: 992–994
Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K, Mishina M (1992) Functional characterization of a hete—romeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70–74
Meldrum B (1994) Neuroprotection by NMDA and non-NMDA glutamate antagonists. In: Palfreyman MG, Reynolds IJ, Skolnick P (eds) Direct and allosteric control of glutamate receptors. CRC Press, Boca Raton, pp 127–138
Miller R, La Grone J, Skolnick P, Boje KM (1992) High-performance liquid chromato¬graphic assay for 1-aminocyclopropanecarboxylic acid from plasma and brain. J Chromatogr 578: 103–108
Muir KW, Grosset DG, Gamzu E, Lees KR (1994) Pharmacological effects of the noncompetitive NMD A antagonist CNS 1102 in normal volunteers. Br J Clin Pharmacol 38: 33–38
Patel J, Zinkand WC, Thompson C, Keith R, Salama A (1990) Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 54: 849–854
Pizzi M, Fallacara C, Arrighi V, Memo M, Spano PF (1993) Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 61: 683–689
Robinson MB, Coyle JT (1987) Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J 1: 446–455
Sheardown MJ, Suzdak PD, Nordholm L (1993) AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol 236: 347–353
Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144–147
Skolnick P, Marvizon J, Jackson B, Monn J, Rice K, Lewin A (1989) Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropane-carboxylates. Life Sei 45: 1647–1655
Skolnick P, Miller R, Young A, Boje K, Trullas R (1992) Chronic treatment with 1-aminocyclopropane-carboxylic acid desensitizes behavioral responses to agents acting at the N-methyl-D-aspartate receptor complex. Psychopharmacol 107: 489–496
Sonsalla PK, Riordan DE, Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506–512
Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan DS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16: 165–174
von Lubitz D, Lin R, McKenzie R, Devlin T, McCabe RT, Skolnick P (1992) A novel treatment of global cerebral ischemia with a glycine partial agonist. Eur J Pharmacol 219: 153–158
Wafford KA, Bain CJ, Le Bourdelles B, Whiting PJ, Kemp JA (1993) Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuro Report 4: 1347–1349
Watson G, Lanthorn TH (1990) Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor associated glycine site. Neuropharmacol 29: 727–730
Williams K (1993) Ifenprodil discriminates subtypes of N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851–859
Witkin J, Steele T (1992) Effects of strychnine-insensitive glycine receptor ligands on discriminative stimulus effects of N-methyl-D-aspartate (NMDA) channel antago¬nists. Abstr Soc Neurosci 18: 447, #192.16
Xue D, Huang Z-G, Barnes K, Lesiuk HJ, Smith KE, Buchan AM (1994) Delayed treatment with AMPA, but not NMDA, antagonists reduce neocortical infarction. J Cereb Blood Flow Metab 14: 251–261
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag/Wien
About this paper
Cite this paper
Fossom, L.H., Skolnick, P. (1997). Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias. In: Mizuno, Y., Youdim, M.B.H., Calne, D.B., Horowski, R., Poewe, W., Riederer, P. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6844-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6844-8_24
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82934-9
Online ISBN: 978-3-7091-6844-8
eBook Packages: Springer Book Archive